Skip navigation
Veuillez utiliser cette adresse pour citer ce document : http://repositorio.unb.br/handle/10482/48134
Fichier(s) constituant ce document :
Il n'y a pas de fichiers associés à ce document.
Titre: Antifungal activity of sustainable histone deacetylase inhibitors against planktonic cells and biofilms of Candida spp. and Cryptococcus neoformans
Auteur(s): Oliveira, Andressa Souza de
Oliveira, Jonathas Sales de
Kumar, Rajender
Silva, Fabiana Brandão Alves
Fernandes, Mirele Rodrigues
Nobre, Feynman Dias
Costa, Anderson da Cunha
Albuquerque, Patrícia
Sidrim, José Júlio Costa
Rocha, Marcos Fábio Gadelha
Santos, Flavia Almeida
Srivastava, Vaibhav
Romeiro, Luiz Antonio Soares
Brilhante, Raimunda Sâmia Nogueira
metadata.dc.contributor.affiliation: University of Brasilia, Faculty of Medicine, Tropical Medicine Centre, Laboratory of Development of Therapeutic Innovations
University of Brasilia, Faculty of Health Sciences, Postgraduate Program in Pharmaceutical Sciences
Federal University of Ceará, Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Centre
AlbaNova University Center, KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Chemistry, Division of Glycoscience
University of Brasilia, Faculty of Medicine, Postgraduate Program in Tropical Medicine
Federal University of Ceará, Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Centre
Federal University of Ceará, Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Centre
Federal University of Ceará, Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Centre
University of Brasília. Campus Ceilândia
Federal University of Ceará, Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Centre
Federal University of Ceará, Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Centre
Federal University of Ceará, Department of Physiology and Pharmacology, Laboratory of Natural Products
AlbaNova University Center, KTH Royal Institute of Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Chemistry, Division of Glycoscience
University of Brasilia, Faculty of Medicine, Tropical Medicine Centre, Laboratory of Development of Therapeutic Innovations
University of Brasilia, Faculty of Health Sciences, Postgraduate Program in Pharmaceutical Sciences
University of Brasilia, Faculty of Medicine, Postgraduate Program in Tropical Medicine
Federal University of Ceará, Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Specialized Medical Mycology Centre
Assunto:: Antifúngicos
Inibidores de histonas desacetilases
Ácido hidroxâmico
Biofilme
Date de publication: 8-aoû-2023
Editeur: Oxford University Press on behalf of The International Society for Human and Animal Mycology
Référence bibliographique: OLIVEIRA, Andressa Souza de et al. Antifungal activity of sustainable histone deacetylase inhibitors against planktonic cells and biofilms of Candida spp. and Cryptococcus neoformans. Medical Mycology, [S. l.], v. 61, n. 8, myad073, ago. 2023. DOI: https://doi.org/10.1093/mmy/myad073.
Abstract: The limited therapeutic options for fungal infections and the increased incidence of fungal strains resistant to antifungal drugs, especially Candida spp., require the development of new antifungal drugs and strategies. Histone deacetylase inhibitors (HDACi), like vorinostat, have been studied in cancer treatment and have antifungal effects, acting alone or synergistically with classical antifungals. Here we investigated the antifungal activity of two novel sustainable HDACi (LDT compounds) based on vorinostat structure. Molecular docking simulation studies reveal that LDT compounds can bind to Class-I HDACs of Candida albicans, C. tropicalis, and Cryptococcus neoformans, which showed similar binding mode to vorinostat. LDT compounds showed moderate activity when tested alone against fungi but act synergistically with antifungal azoles against Candida spp. They reduced biofilm formation by more than 50% in C. albicans (4 μg/mL), with the main action in fungal filamentation. Cytotoxicity of the LDT compounds against RAW264.7 cells was evaluated and LDT536 demonstrated cytotoxicity only at the concentration of 200 μmol/L, while LDT537 showed IC50 values of 29.12 μmol/L. Our data indicated that these sustainable and inexpensive HDACi have potential antifungal and antibiofilm activities, with better results than vorinostat, although further studies are necessary to better understand the mechanism against fungal cells.
metadata.dc.description.unidade: Faculdade de Medicina (FM)
Faculdade de Ciências da Saúde (FS)
Departamento de Farmácia (FS FAR)
metadata.dc.description.ppg: Programa de Pós-Graduação em Ciências Farmacêuticas
Programa de Pós-Graduação em Medicina Tropical
DOI: https://doi.org/10.1093/mmy/myad073
metadata.dc.relation.publisherversion: https://academic.oup.com/mmy/article/61/8/myad073/7239295
Collection(s) :Artigos publicados em periódicos e afins

Affichage détaillé " class="statisticsLink btn btn-primary" href="/jspui/handle/10482/48134/statistics">



Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.